Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481608 · ClinicalTrials.gov registry record · NA
The Effect of Dietary Lauric Acid on the Production of the LRH-1 Ligand, Dilauroylphosphatidylcholine
A NA study, sponsored by Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03481608 is a NA study that has completed, run by Cornell University. The registered enrollment target is 10 participants.
The verdict
NCT03481608, a NA study, has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
A phosphatidylcholine species enriched with lauric acid at both the sn-1 and sn-2 positions, dilauroylphosphatidylcholine (DLPC), was recently identified as a ligand for the nuclear receptor, liver receptor homolog-1 (LRH-1). To date, DLPC has not been reported in vitro or in vivo, and has yet to be catalogued in the human metabolomics database. This intervention trial aims to determine the impact of consumption of dietary lauric acid, in the form of coconut oil (49% lauric acid), can facilitate the production of DLPC in humans.
Interventions
- OTHER Lauric acid (coconut oil)
- OTHER No Lauric acid (olive oil)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-19 |
| Est. Completion | 2018-04-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03481608
The ClinicalTrials.gov registry entry for NCT03481608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lauric acid (coconut oil) is the first listed.
NCT03481608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03481608 about?
NCT03481608 is a clinical study titled "The Effect of Dietary Lauric Acid on the Production of the LRH-1 Ligand, Dilauroylphosphatidylcholine". A phosphatidylcholine species enriched with lauric acid at both the sn-1 and sn-2 positions, dilauroylphosphatidylcholine (DLPC), was recently identified as a ligand for the nuclear receptor, liver receptor homolog-1 (LRH-1). To date, DLPC has not been reported in vitro or in vivo, and has yet to be...
What is the current status of trial NCT03481608?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-03-19. Estimated completion is 2018-04-22.
What interventions are being tested in trial NCT03481608?
The interventions under investigation include: Lauric acid (coconut oil) (OTHER), No Lauric acid (olive oil) (OTHER).
Who is sponsoring clinical trial NCT03481608?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.